In order to design new antitumor drugs and study the relationship between antitumor and anti-oxidative activity of spin-labeled derivatives of podophyllotoxin, five novel pyrroline spin-labeled 4β-N-substituted-amino acid-4′-O-demethylepipodophyllotoxin compounds (11a-e) (Scheme 2) were synthesized and evaluated. Their cytotoxicity against three tumor cell lines (human lung carcinoma A-549, human leukemia cell HL-60 and multiple myeloma RPMI-8226) has been evaluated using a MTT-based assay in vitro. Also, we determined malondialdehyde (MDA) in liver and kidney homogenate of SD rats by the TBA method. The five new compounds showed either superior or comparable inhibitory activity against A-549, HL-60 and RPMI-8226 cell lines compared with etoposide (VP-16, 2) , and all the tested compounds showed more significant antioxidant activities than VP-16. Furthermore, the partition coefficients were measured and preliminary structure-activity relationships are presented.
Podophyllotoxin (1) and related derivatives are well known to have pronounced antineoplastic and antiviral properties [1] . Etoposide (2, VP-16) and teniposide (4, VM-26), which are semisynthetic derivatives of podophyllotoxin (Figure 1, 1) , are drugs used clinically against various cancers, including small cell lung cancer, testicular carcinoma, lymphoma, and Kaposi's sarcoma [2] . However, their therapeutic use is often hindered by problems such as acquired drug-resistance and poor water solubility [3] . To obtain better therapeutic agents, etopophos (3), NK611 (5), as well as GL331 and TOP-53 were developed [1] . Etopophos (3), a water-soluble pro-drug of 2, is readily converted in vivo by endogenous phosphatase to the active drug 2 and exhibits pharmacological and pharmacokinetic profiles similar to those of 2. The bioavailability in vivo was increased through this pro-drug approach [4] . NK611 and GL331 are presently under clinical trial. GL-331 was more potent than 2 as a topoisomerase II inhibitor, and, more notably, overcame multidrugresistance in many cancer cells, including 2-resistant cancer cell lines [5] .
The stable nitroxides have a wide range of activities in biological tissues. Some studies have shown that the introduction of a nitroxyl moiety can lead to fast decomposition, higher alkylating ability, lower carbamoylating activity, better antimelanomic activity, lower general toxicity, and penetration of cell membranes as a transport [6] . Nitroxides possess superoxide dismutase (SOD) mimetic activity and have been shown to prevent oxidative damage in various biological systems [7] . There have been reports that the nitroxides have a favorable effect on the toxicity and anticancer activity of 6-mercaptopurine, which may be Scheme 1: Preparation of compounds 9a-e. due in part to the antioxidant activity of the nitroxides [8] . A number of spin-labeled nitroxide derivatives of podophyllotoxin were synthesized by our group, and results showed that these derivatives had significant cytotoxic activity compared with that of the parent compound (1) [9] . Among them, GP-11 ( Figure 1, 6 ) was reported as a low immunosuppressive antitumor agent, which is almost equipotent with 2 [2]. In this paper, we report the synthetic approach to the spin-labeled podophyllotoxin derivatives and their pharmacological evaluation as antioxidant and antitumor agents.
Biological activities: Compounds 11a-e were evaluated for their cytotoxic activity against three cell lines (A-549, HL-60 and RPMI-8226) in vitro. As shown in Table 1 , compounds 11a, 11b and 11c showed cytotoxic activity that was either superior to or comparable with that of 2 against the tested cell lines. The sequence of cytotoxic activity was: 11c ≈ 11b > 11a > 11d > 11e.
As to the anti-oxidant property, the ranking of activity was: 11c >11b > 11a > 11d > 11e. Among them, 11b, 11c and 11a exhibited the most potent cytotoxicity and antioxidant activity compared with the others. 11d and 11e were inactive, because they have a large substituent and poor water solubility. So we have found that podophyllotoxin derivatives built up with the same pyrroline nitroxides connected by different L-amino acids showed different cytotoxic activity on tumor cells. The relationship between the cytotoxic activity and the different kinds of amino acids indicated that some groups, such as "CH 3 " (11b) and "CH 2 Ph" (11c), may be important for cytotoxic activity. So, in order to obtain podophyllotoxin derivatives with good biological activity, it seems essential to consider such substituents at those positions. For biological activity it is also important to find a balance between the size of the substituent and the partition coefficients. As seen in Table 1 , all the compounds have better antioxidant activity than that of 2. Especially we found that the sequence of antioxidant activity is consistent with cytotoxic activity. That is to say that the compounds with higher cytotoxic activity have higher anti-oxidant activity. The nitroxides significantly potentiated the antitumor effect of the podophyllotoxin derivatives.
The results in Table 1 reveal that the structure of the L-amino acid linked nitroxyl radical moiety could exhibit a beneficial modifying effect on the pharmacological properties of podophyllotoxin (1). It is suggested that the cytotoxicity of these compounds against tumor cells improved with increased antioxidant activity (11c, 11b and 11a vs 11d and 11e) . The spinlabeled amino acid-linked derivatives of podophyllotoxin have promise in antitumor chemotherapy, not only because of their superior cytotoxic activities, but also because they can be monitored by ESR in pharmacological experiments.
Experimental
General: Melting points were determined using a Kofler apparatus and were uncorrected. IR, ESIMS and ESR, spectra were measured on a Nicolet NEXUS 670 FT-IR spectrometer, Bruker Daltonics ESQ6K spectrometer, and Bruker A300 X-band EPR spectrometer, respectively. The SD rats were supplied by the Laboratory Animal Center of Lanzhou University, Lanzhou, China.
Compounds 9a-e were prepared according to previously published methods (Scheme 1). 1-Oxyl-2,2,5,5tetramethylpyrroline-3-carboxylic acid (8), prepared from 7 [10]; was esterified with ethyl chloroformate in Spin-labeled derivatives of podophyllotoxin Natural Product Communications Vol. 5 (2) 2010 243 the presence of a catalytic amount of triethylamine to give quantitative yields of its higher reactive mixed anhydride; which was readily converted into the corresponding acid azide [11] . Reaction of the freeradical acid azide with the corresponding amino acids in the presence of magnesium oxide at room temperature afforded N-(1-oxyl-3-carbonyl-2,2,5,5-tetramethylpyrroline) amino acids (9a-e).
The synthetic route to the target compounds 11a-e is depicted in Scheme 2. Briefly, 4β-amino-4′demethylepipodophyllotoxin (10) prepared from podophyllotoxin (1) [12] was condensed with the appropriate nitroxide amino acids 9a-e in the presence of 1-ethyl-3-(3-dimethyllaminopropyl)carbodiimide hydrochloride (EDC•HCl) and 1-hydroxybenzotriazole hydrate (HOBT) to provide the target compounds 11a-e.
Cytotoxicity assay:
Tumor cells were provided by Lanzhou General Hospital. A-549 cells were cultured in DMEM (H), and HL-60 and RPMI-8226 cells in RPMI 1640 medium, supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 U/mL penicillin, 100 mg/mL streptomycin, and 10 mM PBS buffer. Cells were incubated at 37ºC in a 5% CO 2 atmosphere. The MTT colorimetric assay was used to determine growth inhibition. 6000-10000 cells/well were plated in 96-well plates and allowed to attach for 24 h. Spin-labeled derivatives of podophyllotoxin were dissolved in brine. Cells were exposed, in triplicate, to concentrations of each compound of 0.08 μM, 0.4 μM, 2 μM, 10 μM, and 50 μM for either 48 h or 72 h. Then the media were aspirated, and 100 μL of a 5 mg/mL MTT solution (diluted in sterile PBS), diluted in serum-free media, was added to each well. After 4 h of incubation, the solution was centrifuged for 10 min at 2000 rpm, the limpid solution extracted carefully, and to it was added 200 μL DMSO; the mixture was then shaken using an oscillator. The absorbance at λ 570 was determined on a Mutiskan Mk3 (Thermo Labsystems) plate reader. IC 50 values were determined from a log plot of percent of control versus concentration.
In tissues antioxidant activity assay:
The extent of lipid peroxidation was assessed using a modification of the thiobarbituric acid (TBA) assay [13] . Determination of malondialdehyde content (MDA) in liver, kidney and heart homogenates of SD rats was carried out using 5% in 0.9% NaCl solution. The tissue homogenate (1 mL) was incubated with either test compounds or vehicle (Me 2 SO 2.5 mL/L) at 37ºC for 10 min. Fe 2+ -ascorbic acid solution was added. After 30 min incubation, MDA was determined by TBA colorimetric analysis. The absorbance at 532 nm was determined using an UV spectrophotometer. IC 50 values were determined from 50% of control versus concentration. Each compound was assayed twice in quadruplicate.
Determination of partition coefficients:
The partition coefficient (P) was determined according to the standard method [14] , and calculated from the equation: P = (compound in 1-octanol) / (compound in water). The reported P values are an average of 3 measurements. (11a-e) : A solution of a mixture of the appropriate N-(1-oxyl-3-carbonyl-2,2,5,5-tetramethylpyrroline) amino acid (9a-e) (1.0 mM), 10 (1.0 mM) and EDC•HCl (1.2 mM) in dry CH 2 Cl 2 (20 mL) and HOBT (1.5 mM) was added under argon and the reaction mixture was stirred for 12 h and monitored by TLC. The reaction mixture was washed with water and the oil layer was evaporated. The residue was separated by column chromatography on silica gel with light petroleum-acetone as eluant.
General procedure for synthesis of target compounds

N-(1′-Oxyl-3′-carboxyl-2′,2′,5′,5′-tetramethylpyrroline)-glycine-4-β-NH 2 -4′-demethylepipodophyllotoxin acylamide (11a): Yield 42%
[α] 23 D : -67 (c 0.5, CHCl 3 ). MP: 168-170ºC. IR (KBr): 3378, 2969, 2936, 1771, 1717, 1603, 1509, 1484, 1379, 1331 N-(1′-Oxyl-3′-carboxyl-2′,2′,5′,5′-tetramethylpyrroline) -alanine-4-β-NH 2 -4′-demethylepipodophyllotoxin acylamide (11b): Yield 46%.
[α] 23 D : -56 (c 0.5, CHCl 3 ). MP: 154-156ºC. IR (KBr): 3327, 2976 3327, , 2931 3327, , 1776 3327, , 1718 3327, , 1627 3327, , 1509 3327, , 1484 3327, , 1368 3327, , 1336 3327, (NO•), 1233 3327, , 1129 3327, , 1036 N-(1′-Oxyl-3′-carboxyl-2′,2′,5′,5′-tetramethylpyrroline) -phenylalanine-4-β-NH 2 -4′-demethylepipodophyllotoxin acylamide (11c): Yield 51%.
[α] 23 D : -66 (c 0.5, CHCl 3 ) MP: 144-146ºC IR (KBr): 3373, 2931 3373, , 1771 3373, , 1603 3373, , 1510 3373, , 1483 3373, , 1376 3373, , 1332 , 1229, 1117, 1037, cm-1 ESR: g 0 = 2.0058; An = 14.86 Gs HRMS-ESI: m/z [M+H] + calcd for C 39 H 43 O 10 N 3 : 713.2943 3 : 713. , Found: 713.2937 N-(1′-Oxyl-3′-carboxyl-2′,2′,5′,5′-tetramethylpyrroline) -methionine-4-β-NH 2 -4′-demethylepipodophyllotoxin acylamide (11d): Yield 47%.
[α] 23 D : -32 (c 0.5, CHCl 3 ). MP: 132-134ºC. IR (KBr): 3374, 2976 3374, , 2929 3374, , 1770 3374, , 1667 3374, , 1620 3374, , 1513 3374, , 1484 3374, , 1362 3374, , 1330 3374, (NO•), 1229 3374, , 1117 3374, , 1036 N-(1′-Oxyl-3′-carboxyl-2′,2′,5′,5′-tetramethylpyrroline) -proline-4-β-NH 2 -4′-demethylepipodophyllotoxin acylamide (11e): Yield 40%.
[α] 23 D : -78 (c 0.5, CHCl 3 ). MP: 118-120ºC. IR (KBr): 3346, 2976 3346, , 2933 3346, , 1775 3346, , 1657 3346, , 1609 3346, , 1514 3346, , 1484 3346, , 1373 3346, , 1328 3346, (NO•), 1227 3346, , 1113 3346, , 1035 
